"Heterografts" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tissues, cells or organs transplanted between animals of different species.
| Descriptor ID |
D064593
|
| MeSH Number(s) |
A01.941.875
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Heterografts".
Below are MeSH descriptors whose meaning is more specific than "Heterografts".
This graph shows the total number of publications written about "Heterografts" by people in this website by year, and whether "Heterografts" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 7 | 7 |
| 2014 | 0 | 13 | 13 |
| 2015 | 0 | 14 | 14 |
| 2016 | 1 | 6 | 7 |
| 2017 | 0 | 16 | 16 |
| 2018 | 1 | 9 | 10 |
| 2019 | 0 | 5 | 5 |
| 2020 | 1 | 6 | 7 |
| 2021 | 2 | 10 | 12 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heterografts" by people in Profiles.
-
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis. Cancer Res. 2024 07 02; 84(13):2060-2072.
-
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series. Clin Cancer Res. 2024 May 15; 30(10):2272-2285.
-
Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Mol Cancer Res. 2024 04 02; 22(4):329-336.
-
The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer. Cold Spring Harb Perspect Med. 2024 04 01; 14(4).
-
Defining the challenges and opportunities for using patient-derived models in prostate cancer research. Prostate. 2024 May; 84(7):623-635.
-
Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs). Pathol Res Pract. 2024 Mar; 255:155163.
-
Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models. J Immunother Cancer. 2024 01 09; 12(1).
-
Xenograft recipients and the right to withdraw from a clinical trial. Bioethics. 2024 May; 38(4):308-315.
-
Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer. Nat Commun. 2023 Nov 22; 14(1):7600.
-
Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model. Haematologica. 2023 09 01; 108(9):2513-2519.